Hidden clot risk in rare heart disease revealed by CT scans
NCT ID NCT07648303
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses advanced CT scans to find out how common blood clots are inside the heart chambers of people with cardiac amyloidosis, a condition where abnormal proteins build up in the heart. Researchers will scan 200 adults diagnosed with this disease to detect clots that may raise stroke risk, even in those without irregular heartbeats. The goal is to better understand who is at risk and improve prevention strategies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could reveal how often dangerous blood clots form in the hearts of people with cardiac amyloidosis, helping doctors better prevent strokes.
What could go wrong
This is an observational study, not a treatment trial. It will not test any new therapy, and the findings may not apply to all patients with cardiac amyloidosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu Dijon Bourogne
Dijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••